Indonesian Journal of Clinical Pathology and Medical Laboratory (IJCPML)
Vol. 32 No. 2 (2026)

VITAMIN D RECEPTOR (VDR) AND VITAMIN D LEVELS IN LEUKEMIA AND LYMPHOMA PATIENTS

Anggraini Iriani (Department of Clinical Pathology, Faculty of Medicine, Yarsi University/Yarsi Hospital, Jakarta)
Andhika Rachman (Department of Hematology Oncology, Dr. Cipto Mangunkusumo Hospital, Jakarta)
Marsya Kaila Fatina (Faculty of Medicine, Andalas University, Padang)
Fiona Valerie Muskananfola (Faculty of Medicine, University of Indonesia, Jakarta)
Media Fitri Isma Nugraha (Research Center for Pharmaceutical Ingredients and Traditional Medicine-National Research and Innovation Agency, Cibinong)
Rizka Kurnia Gemilang (Faculty of Medicine, Yarsi University, Jakarta)
Andi Trisnandi (Genomics Laboratory, Bunda Hospital, Jakarta)



Article Info

Publish Date
13 Mar 2026

Abstract

In leukemia and lymphoma, vitamin D exerts anti-tumor effects mediated by its binding to the vitamin D receptor (VDR). Vitamin D is related to cancer prognosis and response to therapy. However, the prevalence of vitamin D deficiency remains significantly high among the Indonesian population. This study aims to determine the profile of vitamin D and vitamin D receptor (VDR) levels in leukemia and lymphoma patients. This study design was a cross-sectional with a comparative analysis of vitamin D and its receptors, conducted on adult leukemia-lymphoma patients and control samples. Vitamin D examination was completed on 180 samples of 123 leukemia and lymphoma patients, and 57 controls. Vitamin D receptor (VDR) examination was conducted on 45 leukemia and lymphoma patients and 57 controls. The prevalence of vitamin D deficiency in the leukemia and lymphoma group was 85.4%.  Subgroup analysis revealed that the prevalence of vitamin D deficiency was significantly higher in leukemia and lymphoma patients aged ≤40 years compared to their respective control group (p =0.039). There was no significant vitamin D receptor level between leukemia and lymphoma and the control group based on all age groups, male, and vitamin D status. Vitamin D receptor level was 0.53 (0.19) ng/mL in leukemia and lymphoma females, lower than the control group 0.73 (0.73) ng/mL, significantly. This study concluded that leukemia and lymphoma patients predominantly have vitamin D deficiency. Vitamin D receptor level is lower in females with leukemia and lymphoma than in the normal population. Vitamin D receptor can be considered as an adjunct marker in assessing vitamin D status in leukemia lymphoma cases.

Copyrights © 2026






Journal Info

Abbrev

patologi

Publisher

Subject

Biochemistry, Genetics & Molecular Biology Health Professions Medicine & Pharmacology Neuroscience

Description

Indonesian Journal of Clinical Pathology and Medical Laboratory (IJCPML) is a journal published by “Association of Clinical Pathologist” professional association. This journal displays articles in the Clinical Pathology and Medical Laboratory scope. Clinical Pathology has a couple of ...